We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+16.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$720B
AUM Growth
+$134B
Cap. Flow
+$32.3B
Cap. Flow %
4.49%
Top 10 Hldgs %
26.15%
Holding
14,080
New
1,720
Increased
5,716
Reduced
5,055
Closed
1,538

Sector Composition

Rank Sector Weight
1 Technology 1.79%
2 Consumer Discretionary 0.82%
3 Financials 0.79%
4 Healthcare 0.66%
5 Industrials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGR icon
13026
Gogoro
GGR
$58.8M
-3,110
Closed -$16.8K
GHY
13027
PGIM Global High Yield Fund
GHY
$472M
-25,481
Closed -$342K
GII icon
13028
State Street SPDR S&P Global Infrastructure ETF
GII
$939M
-28,760
Closed -$1.78M
GJUN icon
13029
FT Vest US Equity Moderate Buffer ETF June
GJUN
$534M
-54,175
Closed -$1.91M
GLBS icon
13030
CALL
Globus Maritime Ltd
GLBS
$83.1M
-22,100
Closed -$26.7K
GLDD
13031
PUT
DELISTED
Great Lakes Dredge & Dock
GLDD
-100,400
Closed -$873K
GLP icon
13032
CALL
Global Partners
GLP
$1.71B
-20,400
Closed -$1.09M
LKFT
13033
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.9B
-95,700
Closed -$2.4M
GLRE icon
13034
PUT
Greenlight Captial
GLRE
$507M
-22,300
Closed -$302K
CBIO
13035
CALL
Crescent Biopharma
CBIO
$630M
-219
Closed -$4.6K
CBIO
13036
Crescent Biopharma
CBIO
$630M
-306
Closed -$6.42K
MRDN
13037
PUT
Meridian Holdings Inc
MRDN
$179M
-1,083
Closed -$25.6K
XRN
13038
CALL
Chiron Real Estate Inc
XRN
$494M
-4,120
Closed -$180K
GNE icon
13039
PUT
Genie Energy
GNE
$402M
-10,600
Closed -$160K
GNLX icon
13040
Genelux
GNLX
$123M
-157,331
Closed -$416K
GNOM icon
13041
Global X Genomics & Biotechnology ETF
GNOM
$92.8M
-13,273
Closed -$422K
GNTX icon
13042
CALL
Gentex
GNTX
$4.97B
-11,200
Closed -$261K
GNTX icon
13043
PUT
Gentex
GNTX
$4.97B
-18,700
Closed -$436K
GOCO
13044
DELISTED
GoHealth
GOCO
-17,632
Closed -$216K
GOGL
13045
CALL
DELISTED
Golden Ocean Group
GOGL
-86,800
Closed -$693K
GOLF icon
13046
CALL
Acushnet Holdings
GOLF
$5.24B
-5,300
Closed -$364K
GOLF icon
13047
PUT
Acushnet Holdings
GOLF
$5.24B
-4,200
Closed -$288K
GOOY icon
13048
YieldMax GOOGL Option Income Strategy ETF
GOOY
$233M
-33,440
Closed -$395K
GORV
13049
DELISTED
Lazydays
GORV
-1,727
Closed -$16.8K
GOTU icon
13050
Gaotu Techedu
GOTU
$403M
-10,940
Closed -$37.5K

Similar funds

Jeff Yass's Q2 2025 Portfolio in Review

As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.

  • Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
  • Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
  • Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
  • Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
  • Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
  • Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.